№ files_lp_3_process_7_024386
File format: docx Character count: 24471 File size: 186 KB
Year: 2015
Region / city: United Kingdom
Topic: Immunisation
Document type: Public Health Guideline
Organization / institution: Public Health England
Author: Elizabeth Graham, Mary Ramsay, David Green
Target audience: Healthcare professionals, Registered Nurses, Paramedics
Period of validity: From 15 December 2015 to 30 November 2017
Approval date: 15 December 2015
Amendment date: N/A
Expiry date: 30 November 2017
Version: v01.00
Review date: 1 June 2017
Reference number: DTaP/IPV/Hib PGD
Note: Change history
Version 1.00: New PHE PGD template, 15 December 2015
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Diphtheria, Tetanus, Acellular Pertussis and Inactivated Poliomyelitis Vaccine Patient Group Direction (PGD)
Year: 2025
Region / City: England
Topic: Immunisation
Document Type: Patient Group Direction (PGD)
Organisation / Institution: UK Health Security Agency (UKHSA)
Author: Suki Hunjunt, Rebecca Cordery, Greta Hayward
Target Audience: Healthcare practitioners
Period of Validity: From 1 November 2025 to 1 November 2028
Approval Date: 24 September 2025
Revision Date: 23 September 2025
Haemophilus influenzae type b and meningococcal C conjugate vaccine (Hib/MenC) Patient Group Direction (PGD)
Reference no: Hib/MenC PGD
Version no: v6.0
Valid from: 1 July 2025
Expiry date: 30 April 2026
Authorising organisations: UK Health Security Agency (UKHSA)
Target audience: Registered healthcare practitioners
Responsible body: UKHSA
Note: Amendment history
v1.0 and v2.0: See previous versions of this PGD template for details (19 January 2016 to 23 April 2018)
v3.0: PHE Hib/MenC PGD amended to: include vaccination of individuals for the prevention of secondary cases of meningococcal group C disease (24 April 2018)
v4.0: PHE Hib/MenC PGD amended to: remove reference to individuals with an underlying medical condition (5 March 2020)
v5.0: UKHSA Hib/MenC PGD amended to: include minor rewording of standard text, layout and formatting changes (4 May 2022)
v6.0: UKHSA Hib/MenC PGD amended to: include minor rewording, updated references, and changes to the childhood immunisation schedule (2 June 2025)
Developed by: Christina Wilson (Lead Pharmacist), Professor Shamez Ladhani (Paediatric Infectious Diseases Consultant), David Green (Nurse Consultant for Immunisation Programmes)
Peer-reviewed by: UKHSA Immunisations PGD Expert Panel
Date approved: 2 June 2025
Topics: DTaPIPVHib Poliomyelitis Haemophilus